California biotech company gets FDA approval for EpiPen alternative for kidsA new FDA-approved nasal spray offers a needle-free alternative to EpiPens for treating severe allergic reactions in children aged 4 and up.
Cancer family 'financially broken' by benefits waitFamilies of children with cancer are financially struggling due to delays in receiving benefits they need to cover extra living costs.
The BMA's stance on puberty blockers defies the key principle of medicine: first, do no harm | Sonia SodhaDoctors should follow evidence-based clinical guidelines for life-altering medical interventions, especially with gender-questioning children.